Evidence map›Paper›PMID 35314619›Full record

ArticlePharmacy (Basel, Switzerland)2022

Evaluation of Current Community Pharmacist Practice in Saudi Arabia-A Cross-Sectional Study from Pharmacists' Perspective (Part II).

Mohammad Alhazmi, Abdulmajeed Bajuayfir, Ejaz Cheema, Mahmoud Elrggal, Majid Ali

Open access · goldAbstract read
In one paragraph

Article in Pharmacy (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Over-the-Counter Medication Use among Parents in Saudi Arabia.International journal of environmental research and public health · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Mohammad AlhazmiPharmacy Services, Ministry of Health, Al-Baha 11176, Saudi Arabia.
Abdulmajeed BajuayfirRetail Department, Al-Dawaa Pharmacies, Al-Khobar 34621, Saudi Arabia.
Ejaz CheemaSchool of Pharmacy, University of Management and Technology, Lahore 54770, Pakistan.
Mahmoud ElrggalFaculty of Pharmacy, Umm Al-Qura University, Makkah 24382, Saudi Arabia.
Majid AliSchool of Life and Medical Sciences, University of Hertfordshire (Hosted by Global Academic Foundation), New Administrative Capital, Cairo 11835, Egypt.
Ministry of Health · SASaad Specialist Hospital · SAUmm al-Qura University · SAUniversity of Management and Technology · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to evaluate the current practice of community pharmacists from patients' and pharmacists' perspectives in Saudi Arabia. This paper presents the pharmacist's perspective. A cross-sectional self-administered online survey was designed to collect responses from community pharmacists in Saudi Arabia from February to April 2021. The questionnaire consisted of several statements related to best practice in community pharmacy. Pharmacists' responses to each statement were scored using a 5-point Likert scale. Higher scores represented a greater extent to which they adhered to best practice in the community pharmacy setting and vice versa. Data of 164 participants were included in the analysis. The minimum median score was related to the statement: Pharmacist explains the main side effects. The maximum median score was related to the statement: Pharmacist explains dosage regimen. Pharmacists aged 30 years or above and non-Saudi pharmacists had significantly higher median scores compared with pharmacists less than 30 years of age (

Indexed as

community pharmacyhealthcare service evaluationpharmaceutical carepharmacist perspectiveSaudi Arabia

Identifiers

PMID35314619
PMCPMC8938769
OpenAlexW4220836071

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.